Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica. [PDF]
PLoS Negl Trop Dis, 2023 Xu J +7 more
europepmc +1 more source
Valeur schistosomicide d'un nouveau dérivé aminonitrothiazole le CIBA 32.644/Ba ou ANT
, 1965 S. Grétillat
openalex +2 more sources
Schistosomicidal Effect of Curcumin
Trends in Applied Sciences Research, 2006 Mahmoud EL-Sherbiny . +4 more
openaire +1 more source
Addressing the oxamniquine in vitro-in vivo paradox to facilitate a new generation of anti-schistosome treatments. [PDF]
Int J Parasitol Drugs Drug Resist, 2023 Toth K +5 more
europepmc +1 more source
Design, Synthesis and Evaluation of Praziquantel Analogues and New Molecular Hybrids as Potential Antimalarial and Anti-Schistosomal Agents. [PDF]
Molecules, 2023 Kasago FM +3 more
europepmc +1 more source
SCHISTOSOMAL MYELORADICULOPATHY IN A NON-ENDEMIC AREA. [PDF]
Rev Paul Pediatr, 2020 Oliveira LS +3 more
europepmc +1 more source
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here? [PDF]
RSC Med Chem, 2020 Dziwornu GA +3 more
europepmc +1 more source
Radicicol, a Novel Lead Compound against the Migratory-Stage Schistosomula of Schistosoma japonicum. [PDF]
Antimicrob Agents Chemother, 2021 Xu L +7 more
europepmc +1 more source
Parasitological and Biochemical Efficacy of the Active Ingredients of Allium sativum and Curcuma longa in Schistosoma mansoni Infected Mice. [PDF]
Molecules, 2021 Abu Almaaty AH +5 more
europepmc +1 more source
Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) Identified from the Library of FDA-Approved Drugs Using Molecular Docking Studies. [PDF]
Biomedicines, 2022 Verma DK, Kapoor S, Das S, Thakur KG.
europepmc +1 more source